source
- ctDNA testing shows promise for renal cell carcinoma and germ cell tumors despite current limitationsExperts discussed how circulating tumor DNA (ctDNA) monitoring, long used in bladder cancer, is being explored for renal cell carcinoma (RCC) and germ cell tumors. In RCC, low tumor shedding has l…
- ctDNA monitoring guides immunotherapy decisions in metastatic urothelial cancerExperts discussed how circulating tumor DNA (ctDNA) testing is being used to follow patients with metastatic urothelial carcinoma and to help shape immunotherapy choices. They noted that a rapid d…